GGrantIndex
Sort

15,842 grants matching pancreatic cancer

N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia

$353,704
Paul Joseph Grippo · University Of Illinois At Chicago · R01 · FY2015 · CA

Investigating a Novel Glutamine Metabolism Pathway in Pancreatic Cancer

$353,696
Alec Kimmelman · Dana-Farber Cancer Inst · R01 · FY2015 · CA

Clinical Tissue Procurement and Sequencing Core

$353,655
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA

Theranostic Nanoparticles For Detection and Treatment of Pancreatic Cancer

$353,654
Lacey R McNally · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2019 · EB

A novel therapy for pancreatic neuroendocrine tumors

$353,627
Asfar S Azmi · Wayne State University · R01 · FY2021 · CA

Flavoproteins in Oxidative Protein Folding

$353,496
Colin Thorpe · University Of Delaware · R01 · FY2019 · GM

Flavoproteins in Oxidative Protein Folding

$353,496
Colin Thorpe · University Of Delaware · R01 · FY2016 · GM

Flavoproteins in Oxidative Protein Folding

$353,496
Colin Thorpe · University Of Delaware · R01 · FY2017 · GM

Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue

$353,419
Pei Wang · University Of Texas Hlth Science Center · R01 · FY2021 · CA

High throughput screens for fatty acid uptake inhibitors

$353,323
Concetta C. Dirusso · Ordway Research Institute, Inc. · R01 · FY2007 · DK

TOR signaling and autophagy in obesity-promoted liver tumorigenesis

$353,140
Michael Karin · University Of California, San Diego · R01 · FY2012 · CA

Light-Triggered Drug Release in Primed Pancreatic Tumors

$353,140
Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2013 · EB

Mechanism of APE1 in DNA damage response

$353,137
Shan Yan · University Of North Carolina Charlotte · R01 · FY2022 · CA

Mechanisms and therapeutic targets of cancer metastasis

$353,134
Gregory L Beatty · University Of Pennsylvania · R01 · FY2024 · CA

Function of TbRIII as a BMP Co-receptor in Human Cancer

$353,126
Gerard C Blobe · Duke University · R01 · FY2011 · CA

Genetic progression of pancreatic mucinous cystic neoplasms to invasive carcinoma

$353,000
Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2012 · CA

Genetic progression of pancreatic mucinous cystic neoplasms to invasive carcinoma

$353,000
Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA

MRI-Guided Dendritic-Cell-Based Vaccine Immunotherapy for Pancreatic Cancer

$352,824
Zhuoli Zhang · Northwestern University At Chicago · R01 · FY2018 · CA

G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??

$352,813
Laurence H Hurley · University Of Arizona · R01 · FY2011 · CA

Intratumoral Metabolic Crosstalk Promotes Therapeutic Resistance in Pancreatic Cancer

$352,808
Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R37 · FY2024 · CA

The JAZF1 Gene and Type 2 Diabetes

$352,800
Jeffrey Sklar · Yale University · R01 · FY2011 · DK

Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics

$352,751
Laura E Strong · Quintessence Biosciences, Inc. · R44 · FY2010 · CA

A Multi-Purpose Nanovehicle for Targeted Boron Neutron Capture Cancer Therapy & I

$352,700
Andrew Webb · Wellesley College · R15 · FY2012 · CA

The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic Cancer

$352,688
David G Denardo · Washington University · R01 · FY2019 · CA

Molecular aspects of gastrinoma

$352,681
Robert Jensen · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK